Insider filing · PTGX
Asif Ali
Chief Financial Officer
profile →
Protagonist Therapeutics, Inc.
PTGX · Healthcare · 36 filings in 24 months
ticker →
Asif Ali sold $534K of Protagonist Therapeutics (PTGX)
Executed Sep 11 2024, disclosed Sep 13 2024, 2 days later.
Value, as filed
$534K
12,000 sh × $44.47
Executed
Sep 11 2024
the trade date, as filed
Disclosed
Sep 13 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AAAsif Ali (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $3.8M of PTGX (46,203 sh across 2 lots, as filed), executed Jan 27.
The name
PTGXHealthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Asif Ali in PTGX
PTGXSALE
Protagonist Therapeutics, Inc.
$185K1,750 sh × $105.47
Exec Apr 20
Filed Apr 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $2.6M
24,765 sh × $104.24
Exec Mar 26
Filed Mar 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $3.8M
46,203 sh across 2 lots
Exec Jan 27
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $708K
8,588 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.5M
24,903 sh × $58.73
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET